Disclosed is a combination pharmaceutical composition comprising a) a homeopathic activated-potentiated form of an antibody to bradykinin, b) an activated-potentiated form of an antibody to histamine and c) a homeopathic activated-potentiated form of an antibody to morphine. Also disclosed is the use of a) a homeopathic activated-potentiated form of an antibody to bradykinin, b) a homeopathic activated-potentiated form of an antibody to histamine and c) a homeopathic activated-potentiated form of an antibody to morphine in the manufacture of a medicament for treating and preventing upper respiratory tract conditions or disorders and the symptoms associated therewith by administration of the combination composition.